menu
shopping_basket 0
Add listing
search
    menu
    Add listing

    MV BioTherapeutics SA

    • Swiss Biotech Association
      Not a member

    We are a Swiss microbiome biotherapeutics company with two key platforms:

    1. ApyraVax with the lead indication of Clostridioides difficile infection
    2. ApyraMed with lead indications as Cancer Immunotherapy Enhancer and Dysbiosis

     

    Location
    Get Directions
    Facts & figures
    • Type of organization
      Private company
    • Year of foundation
      2015
    • Number of employees in Switzerland
      1-9
    Key business
    Core competencies

    You may also be interested in